BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-1.27 Cr | ₹1.62 Cr | ₹19 Cr | ₹-3.82 Cr | ₹-7.50 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BLISS GVS PHARMA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-1.27 Cr |
Mar2023 | ₹1.62 Cr |
Mar2022 | ₹19 Cr |
Mar2021 | ₹-3.82 Cr |
Mar2020 | ₹-7.50 Cr |
How is Net Cash Inflow / Outflow of BLISS GVS PHARMA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-1.27 Cr | Negative | |
Mar2023 | ₹1.62 Cr | -91.35 | |
Mar2022 | ₹19 Cr | Positive | |
Mar2021 | ₹-3.82 Cr | Negative | |
Mar2020 | ₹-7.50 Cr | - |
Compare Net Cash Inflow / Outflow of peers of BLISS GVS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BLISS GVS PHARMA | ₹1,457.2 Cr | -6.1% | 9.6% | 30.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -1.3% | -3.3% | 8.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -1.5% | 0.8% | 42.3% | Stock Analytics | |
CIPLA | ₹121,197.0 Cr | -1.7% | 2.3% | -5.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,618.0 Cr | -1.6% | 8.4% | 10.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,250.0 Cr | -3.3% | -1.4% | 9.8% | Stock Analytics |
BLISS GVS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BLISS GVS PHARMA | -6.1% |
9.6% |
30.3% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses